MS-1020 |
| Catalog No.GC40791 |
MS-1020 es un inhibidor de JAK3 potente y competitivo con ATP. MS-1020 inhibe la seÑalizaciÓn de JAK3/STAT e induce la apoptosis. MS-1020 promueve la muerte celular. MS-1020 disminuye la expresiÓn de los niveles de STAT3 fosforilados en tirosina. MS-1020 tiene el potencial para la investigaciÓn de cÁnceres que albergan seÑalizaciÓn JAK3 aberrante.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1255516-86-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MS-1020 is a cell-permeable inhibitor of janus kinase 3 (JAK3), strongly inhibiting constitutive autophosphorylation of JAK3 in L540 cells when used at 30-50 μM. It is without effect on other JAK isoforms and several other kinases, including Src, Lyn, Akt, EGFR, and ERK1/2. Through its effects on JAK3, MS-1020 blocks phosphorylation of downstream signal transduction and activators of transcription isoforms, reducing the expression of anti-apoptotic genes, leading to cell death.
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *